Basal Insulin Degludec and Glycemic Control Compared to Aspart Via Insulin Pump in Type 1 Diabetes (BIGLEAP): A Single-Center, Open-Label, Randomized, Crossover Trial
- 8 November 2021
- journal article
- research article
- Published by Elsevier BV in Endocrine Practice
- Vol. 28 (2), 165-172
- https://doi.org/10.1016/j.eprac.2021.11.001
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk
This publication has 27 references indexed in Scilit:
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin InjectionsJAMA, 2017
- Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin InjectionsJAMA, 2017
- A Review of the Pharmacological Properties of Insulin Degludec and Their Clinical RelevanceClinical Pharmacokinetics, 2014
- Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology Insulin Pump Management Task ForceEndocrine Practice, 2014
- Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre‐planned meta‐analysis of phase 3 trialsDiabetes, Obesity and Metabolism, 2012
- Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device)Health and Quality of Life Outcomes, 2009
- Hypoglycemia with Intensive Insulin Therapy: A Systematic Review and Meta-Analyses of Randomized Trials of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily InjectionsJournal of Clinical Endocrinology & Metabolism, 2009
- In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargineDiabetic Medicine, 2008
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1993
- The two‐period cross‐over clinical trial.British Journal of Clinical Pharmacology, 1979